Hims & Hers' stock plunges. Here's why Wegovy parent ended its partnership with the company.Market Watch • 06/23/25
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketingPRNewsWire • 06/23/25
HIMS' Subscriptions Power Personalized Care & Recurring Revenue GrowthZacks Investment Research • 06/12/25
Hims & Hers: The ZAVA Acquisition Catapults Growth In Europe's Weight-Loss MarketSeeking Alpha • 06/11/25
Bought $40,000 of Hims & Hers (HIMS) Stock on a YOLO – Is it Time to Sell?24/7 Wall Street • 06/10/25
This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare SpaceThe Motley Fool • 06/07/25
HIMS' Buyouts Fuel International Expansion & Digital Health InnovationZacks Investment Research • 06/05/25